Drug Makers Join Efforts in Research
Ten of the world’s largest pharmaceutical companies said on Wednesday that they would cooperate on research aimed at accelerating drug development, starting with streamlining clinical trials.
Related Posts
-
C-Path and FARA announce collaborative data aggregation project for Friedreich’s ataxia -
New CDISC Data Standard Aids Development of Therapies for Ebola Virus -
Public Workshop: Scientific and Regulatory Considerations for the Analytical Validation of Assays Used in the Qualification of Biomarkers in Biological Matrices -
Considerations for Requiring Subjects to Respond to PRO Instruments Collected Electronically -
Biomarker Qualification: Collaboration, Strategy, and Implementation